Drug-resistant infections are set to kill more people than cancer by 2050. Now a new University of Plymouth spinout company has been established to help tackle the problem - by developing new antibiotics and bringing them to market.
A research group led by scientists from the RIKEN Center for Advanced Intelligence Project (AIP) have developed a novel system that can automatically detect abnormalities in fetal hearts in real-time using artificial intelligence (AI). This technology could help examiners to avoid missing severe and complex congenital heart abnormalities that require prompt treatments, leading to early diagnosis and well-planned treatment plans, and could contribute to the development of perinatal or neonatal medicine.
SWEEPER is designed to operate in a single stem row cropping system, with non-clustered fruits and little leaf occlusion. The BGU team spearheaded efforts to improve the robot's ability to detect ripe produce using computer vision, and has played a role in defining the specifications of the robot's hardware and software interfaces, focusing on supervisory control activities.
Former Vice President Joe Biden and Dr. Jill Biden hosted the national Biden Cancer Summit, on Sept. 21, to highlight the urgent need for creating transformative approaches to cancer prevention, research and treatment. One of the new initiatives announced was the formation of a consortium to advance research into effective treatments for patients with a type of cancer called Gastrointestinal Stromal Tumor (GIST) who do not respond to current standard treatments.
Data acquired by the US Geological Survey on the US Atlantic margin in August 2018 reveal new information about the distribution of gas hydrates in the sector stretching from the upper continental slope to deep water areas offshore New Jersey to North Carolina.
Trendy workout clothes may advertise that special silver nanoparticles embedded in the fabric will cut the sweaty odor that builds up from repeated gym visits. It turns out there's some truth to these claims. In this video, Reactions explains how all that is possible: https://youtu.be/3UcnYMFTzFQ. And don't forget: #NationalNanoDay is October 9, and ACS is celebrating science on the nanoscale all week. To learn more, visit www.acs.org/nano.
Nowadays, hyperspectral images contain a huge amount of data but it is quite difficult to interpret them. In order to do this, one needs to know what characteristics of materials are specified and how they correlate with the results of other measurements. So, developers need atlases of the images themselves, databases, libraries of spectra (their signatures). In addition, remote sensing requires some knowledge in field of physics, chemistry, geology and mathematics.
A clinical trial testing infusions of combination antibodies in people living with HIV has begun at NIH. The early-phase clinical trial will evaluate whether periodic infusions of two highly potent, HIV-specific, broadly neutralizing antibodies (bNAbs)--3BNC117 and 10-1074--are safe in people living with HIV. The study also will gather preliminary data on how effectively the bNAb infusions, delivered together every two to four weeks, suppress HIV following discontinuation of antiretroviral therapy (ART).
Dr. Ben Conley, an electro-optics engineer at the Naval Surface Warfare Center-Crane Division, has developed a special metamaterial to bring full-spectrum infrared to night vision devices. On August 28, the Navy was granted a US patent on Conley's invention.
The test marked the return of a capability that is critical to the United States' role in the development of nuclear fuels, for both the existing fleet and a new generation of advanced reactors under design.